Express Scripts to Webcast Investor Day Meeting
ST. LOUIS, Dec. 20, 2013 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) announced today its intention to release its fourth quarter earnings and 2014 earnings guidance on Thursday, February 20, 2014 after the market closes and has scheduled an investor day meeting in New York City at 8:00 a.m. Eastern Time on February 21, 2014. In addition to discussing fourth quarter earnings and 2014 earnings guidance, senior management will review the Company's strategies to deliver long-term growth and enhance shareholder value. The presentation will also be broadcast via the Internet and can be accessed on the investor relations section of the Express Scripts web site at http://www.express-scripts.com.
A slide presentation will accompany the webcast. Following the meeting, both the slide presentation and the webcast will remain available on the investor relations section of the Express Scripts website for 30 days. RealPlayer or Windows Media Player is needed to listen to the webcast and free downloads of these players are available at the webcast site.
Express Scripts (NASDAQ: ESRX) manages more than a billion prescriptions each year for tens of millions of patients. On behalf of our clients – employers, health plans, unions and government health programs – we make the use of prescription drugs safer and more affordable. Express Scripts uniquely combines three capabilities – behavioral sciences, clinical specialization and actionable data – to create Health Decision Science(SM), our innovative approach to help individuals make the best drug choices, pharmacy choices and health choices. Better decisions mean healthier outcomes.
Headquartered in St. Louis, Express Scripts provides integrated pharmacy benefit management services, including network-pharmacy claims processing, home delivery, specialty benefit management, benefit-design consultation, drug-utilization review, formulary management, and medical and drug data analysis services. The company also distributes a full range of biopharmaceutical products and provides extensive cost-management and patient-care services.
For more information, visit Lab.Express-Scripts.com or follow @ExpressScripts on Twitter.
SOURCE Express Scripts Holding Company
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article